Marietta Dermatology Clinical Research

Marietta, Georgia 30060

0 studies enrolling now · 4 studies all time

What they study most

Atopic Dermatitis, Hidradenitis Suppurativa, Psoriasis

Studies at this site

• Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) — Completed
• Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis — Completed
• A Study of LY3041658 in Adults With Hidradenitis Suppurativa — Completed
• A Study to Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis — Completed